1. Delloye C, Cnockaert N, Cornu O. Bone substituetes in 2003: an overview. Acta Orthop Belg. 2003; 69:1–8.
2. Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: an update. Injury. 2005; 36(Suppl):20–7.
Article
3. Greenwald AS, Boden SD, Goldberg VM, Khan Y, Laurencin CT, Rosier RN. Bone-graft substitutes: facts, fictions, and applications. J Bone Joint Surg. 2001; 83:98–103.
Article
4. Bauer TW, Smith ST. Bioactive materials in orthopaedic surgery: overview and regulatory considerations. Clin Orthop Relat Res. 2002; 395:11–22.
Article
5. Betz RR. Limitations of autograft and allograft: new synthetic solutions. Orthopedics. 2002; 25(Suppl 5):561–70.
Article
6. Bauer TW, Muschler GF. Bone graft materials. An overview of the basic science. Clin Orthop Relat Res. 2000; 371:10–27.
7. Bostman O, Pihlajamaki H. Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review. Biomaterials. 2000; 21:2615–21.
8. Bouxsein ML, Turek TJ, Blake Ca, et al. Recombinant human bone morphogenetic protein-2 accelerates healing in a rabbit ulnar osteotomy model. J Bone Joint Surg. 2001; 83:219–30.
Article
9. Yeh LC, Unda R, Lee JC. Osteogenic protein-1 differentially regulates the mRNA expression of bone morphogenetic proteins and their receptors in primary cultures of osteoblasts. J Cell Physiol. 2000; 185:87–97.
Article
10. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Raiol Endod. 1998; 85:638–46.
11. Wrotniak M, Bielecki T, Gazdzik TS. Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery. Orthop Traumatol Rehabil. 2007; 9:227–38.
12. Dallari D, Savarino L, Stagni C, et al. Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. J Bone Joint Surg. 2007; 89:2413–20.
Article
13. Kitoh H, Kitakoji T, Tsuchiya H, et al. Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis - a preliminary result of three cases. Bone. 2004; 35:892–8.
14. Veillette CJ, McKe MD. Growth factors - BMPs, DBMs, and buffy coat products: are there any proven differences amongst them? Injury. 2007; 38(Suppl 1):38–48.
Article
15. Pietrzak WS, Eppley BL. Platelet rich plasma: biology and new technology. J Craniofac Surg. 2005; 16:1043–54.
Article
16. Marx RE. Platelet-rich plasma: evidence to support its use. Maxillofac Surg. 2004; 62:489–96.
Article
17. Wilde AH, Schickendantz MS, Stulberg BN, Go RT. The incorporation of tibial allografts in total knee arthroplasty. J Bone Joint Surg. 1990; 72:815–24.
Article
18. Stevenson S, Horowitz M. The response to bone allografts. J Bone Joint Surg. 1992; 74:939–50.
Article